- Home
- GOSS vs EP Comparison
GOSS vs EP Comparison
Compare GOSS & EP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- EP
- Stock Information
- Founded
- GOSS 2015
- EP 1983
- Country
- GOSS United States
- EP United States
- Employees
- GOSS N/A
- EP N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- EP Oil & Gas Production
- Sector
- GOSS Health Care
- EP Energy
- Exchange
- GOSS Nasdaq
- EP Nasdaq
- Market Cap
- GOSS 188.6M
- EP 194.1M
- IPO Year
- GOSS 2019
- EP N/A
- Fundamental
- Price
- GOSS $0.84
- EP $5.32
- Analyst Decision
- GOSS Strong Buy
- EP
- Analyst Count
- GOSS 4
- EP 0
- Target Price
- GOSS $7.50
- EP N/A
- AVG Volume (30 Days)
- GOSS 1.5M
- EP 33.7K
- Earning Date
- GOSS 05-06-2025
- EP 05-14-2025
- Dividend Yield
- GOSS N/A
- EP N/A
- EPS Growth
- GOSS N/A
- EP N/A
- EPS
- GOSS N/A
- EP N/A
- Revenue
- GOSS $114,701,000.00
- EP $44,039,178.00
- Revenue This Year
- GOSS N/A
- EP N/A
- Revenue Next Year
- GOSS $172.31
- EP N/A
- P/E Ratio
- GOSS N/A
- EP N/A
- Revenue Growth
- GOSS N/A
- EP 9.71
- 52 Week Low
- GOSS $0.50
- EP $4.06
- 52 Week High
- GOSS $1.55
- EP $8.46
- Technical
- Relative Strength Index (RSI)
- GOSS 37.58
- EP 44.39
- Support Level
- GOSS $0.80
- EP $5.06
- Resistance Level
- GOSS $0.88
- EP $6.05
- Average True Range (ATR)
- GOSS 0.10
- EP 0.56
- MACD
- GOSS -0.01
- EP -0.03
- Stochastic Oscillator
- GOSS 20.24
- EP 32.00
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About EP Empire Petroleum Corporation
Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the US onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.